Resources
Over the past two years the lethal H5N1 strain of bird flu has spread from South East Asia to Europe the Middle East and west Africa, sparking fears of a global pandemic.
GSK vaccine for flu pandemic wins approval
European regulators have approved recommendations from specialists to authorise the pharmaceutical group’s Prepandrix, assuring governments seeking to build up stockpiles
Novartis steps up case for new flu vaccine
Focus on protection against pandemic strains
Related content and features
Clive Cookson
Q&A: How worried should we be?
The sudden appearance of virulent bird flu on a Suffolk turkey farm seems to have taken everyone by surprise.
Q&A: The threat from bird flu
FT science editor Clive Cookson answers your questions.
Search for a cure
Feeling the strain
The World Health Organisation estimates that a ‘bird flu’ pandemic could affect one in four people around the globe. Governments are stockpiling the antiviral drug Tamiflu, the best hope of a cure. But can be enough made in time - and will it work?
Incubating a crisis
Why fight against bird flu centres on Indonesia

As Mt Merapi, Indonesia’s most active volcano, spews out smoke and lava, a disaster is incubating in the farms and villages of Central Java with potentially far greater consequences for human health.
Global threat
Bird flu’s link with the crazy trade in poultry

We still do not know how the H5N1 virus struck the Bernard Matthews farm or where it might strike again, writes Caroline Lucas, a Green party Euro MP for south-east England.
More stories
- Front page
- World
- Companies
- Markets
- Markets Data
- Managed funds
- Lex
- Comment
- Video & Audio
- Management
- Business Education
- Personal Finance
- Arts & Leisure
- Wealth
- In depth
- Special Reports
- Jobs & classified
- Services & tools
"Front page" sub navigation
"World" sub navigation
"US & Canada" sub navigation
"Europe" sub navigation
"UK" sub navigation
"Asia-Pacific" sub navigation
"Middle East" sub navigation
"Americas" sub navigation
"Companies" sub navigation
"Energy" sub navigation
"Industrials" sub navigation
"Transport" sub navigation
"Retail & Consumer" sub navigation
"Health" sub navigation
"Technology" sub navigation
"Financials" sub navigation
"By region" sub navigation
"Columnists" sub navigation
"Companies A-Z" sub navigation
"Markets" sub navigation
"Equities" sub navigation
"FT Trading Room" sub navigation
"Columnists" sub navigation
"Markets Data" sub navigation
"Managed funds" sub navigation
"FTfm" sub navigation
"Lex" sub navigation
"By sector" sub navigation
"Comment" sub navigation
"Columnists" sub navigation
"Video & Audio" sub navigation
"Management" sub navigation
"Columnists" sub navigation
"Business Education" sub navigation
"MBA" sub navigation
"Masters in Management" sub navigation
"EMBA 2009" sub navigation
"Executive education 2009" sub navigation
"Personal Finance" sub navigation
"Investments" sub navigation
"Advice & Comment" sub navigation
"Tools & Calculators" sub navigation
"Compare & Apply" sub navigation
"Arts & Leisure" sub navigation
"Arts" sub navigation
"Pursuits" sub navigation
"Columnists" sub navigation
"Wealth" sub navigation
"In depth" sub navigation
"Special Reports" sub navigation
"Jobs & classified" sub navigation
"Jobs" sub navigation
"Services & tools" sub navigation
"News by email" sub navigation
"About us" sub navigation

Bird flu 






